Encompass Health (NYSE:EHC) Price Target Raised to $120.00 at KeyCorp

Encompass Health (NYSE:EHC) had its price target lifted by stock analysts at KeyCorp from $117.00 to $120.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. KeyCorp’s target price indicates a potential upside of 20.17% from the company’s previous close.

Other equities analysts have also issued research reports about the company. Truist Financial reiterated a “buy” rating and issued a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Royal Bank of Canada lifted their target price on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Barclays boosted their price target on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a report on Friday. StockNews.com cut shares of Encompass Health from a “buy” rating to a “hold” rating in a research report on Friday. Finally, William Blair reissued an “outperform” rating on shares of Encompass Health in a research note on Friday. One equities research analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $107.67.

Encompass Health Stock Up 1.3 %

NYSE EHC opened at $99.86 on Monday. Encompass Health has a 12 month low of $72.37 and a 12 month high of $104.55. The company has a market capitalization of $10.06 billion, a P/E ratio of 22.39, a PEG ratio of 1.18 and a beta of 0.90. The company’s 50 day simple moving average is $96.28 and its 200 day simple moving average is $95.30. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 18.06% and a net margin of 8.48%. Equities research analysts expect that Encompass Health will post 4.76 earnings per share for the current fiscal year.

Institutional Trading of Encompass Health

A number of institutional investors have recently bought and sold shares of the company. CIBC Asset Management Inc raised its stake in shares of Encompass Health by 3.5% during the 3rd quarter. CIBC Asset Management Inc now owns 2,957 shares of the company’s stock worth $286,000 after purchasing an additional 100 shares in the last quarter. Miracle Mile Advisors LLC increased its holdings in Encompass Health by 3.0% in the fourth quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company’s stock worth $354,000 after buying an additional 112 shares during the last quarter. US Bancorp DE raised its position in Encompass Health by 9.6% during the fourth quarter. US Bancorp DE now owns 1,380 shares of the company’s stock valued at $127,000 after acquiring an additional 121 shares in the last quarter. MassMutual Private Wealth & Trust FSB lifted its stake in Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after acquiring an additional 137 shares during the last quarter. Finally, V Square Quantitative Management LLC grew its position in Encompass Health by 53.0% in the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after acquiring an additional 140 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.